Preserving Therapeutic Ketosis During Perioperative Management of Adult-Onset Glucose Transporter Type 1 Deficiency Syndrome: A Case Report and Practical Anesthetic Considerations

The human brain is an energy-hungry organ that usually runs almost exclusively on glucose, a simple sugar derived from the food we eat. For most people, this fuel arrives effortlessly through the bloodstream. However, in a rare condition called Glucose Transporter Type 1 Deficiency Syndrome, a specific protein that acts as a gateway for sugar to enter the brain is broken. Without this gateway, the brain is starved of its primary fuel, leading to chronic energy shortages that can cause seizures, developmental delays, and confusion. To survive and function, the brains of people with this condition must switch to an alternative fuel source: ketone bodies. These are molecules produced by the liver when the body breaks down fats instead of sugars. For these patients, a high-fat, low-carbohydrate diet is not just a lifestyle choice but a medical necessity, keeping their brains supplied with the energy they cannot get from sugar.

The challenge arises when a patient with this condition needs surgery. Standard medical practice often involves giving patients sugar solutions during operations to prevent low blood sugar, a routine that could be dangerous for someone whose brain relies on ketones. If a surgeon or anesthesiologist inadvertently floods the system with glucose, it can shut down the production of ketones, effectively cutting off the brain's only reliable energy supply. Until now, there has been very little guidance on how to manage adult patients with this condition during surgery, as most known cases involve children. A team of doctors at Fukuoka Kinen Hospital recently documented the successful care of an adult woman with this syndrome, showing that it is possible to keep her brain fueled with ketones even while she is under general anesthesia.

The patient was a woman in her forties who had been living with adult-onset Glucose Transporter Type 1 Deficiency Syndrome. Before her diagnosis, she had suffered from unexplained fatigue and general malaise, symptoms that vanished once she began a strict diet designed to keep her body producing ketones. She had no history of seizures or loss of consciousness and was physically active. She was scheduled for a hip surgery to correct a bone alignment issue, a procedure that would require her to be completely unconscious. The medical team faced a delicate balancing act: they needed to keep her asleep and pain-free for nearly two and a half hours without disrupting the metabolic state that kept her brain functioning.

To achieve this, the doctors chose a method of anesthesia called total intravenous anesthesia, which uses only liquid medications delivered through a vein rather than gases breathed through a mask. They administered a steady stream of drugs to induce and maintain sleep, while carefully avoiding any fluids containing glucose. In fact, they went so far as to give her a small amount of fat emulsion during her pre-surgery fast. This fat served as a backup energy source, ensuring her body continued to produce the ketones her brain needed. Throughout the operation, which lasted 147 minutes, the team monitored her depth of sleep and her vital signs with extreme care. They watched her blood sugar levels to ensure they stayed normal, checking that they did not drop too low or spike too high, and they kept a close eye on her acid-base balance to confirm she was in a healthy state of ketosis rather than a dangerous one.

The results were exactly what the team hoped for. The patient's blood sugar remained stable, her insulin levels stayed low, and her ketone levels remained high, indicating her brain was receiving the fuel it required. She woke up smoothly from the anesthesia with no neurological complications and was able to resume her special diet just four hours after the surgery ended. She recovered without any issues and was discharged from the hospital. This case demonstrates that with careful planning, it is entirely feasible to perform surgery on an adult with this rare condition without compromising their brain's energy supply. The key lay in treating the elevated ketone levels not as a warning sign of illness, but as a therapeutic goal to be protected.

The success of this procedure relied on a few critical decisions. First, the team avoided the standard practice of giving sugar solutions, which would have suppressed the body's natural production of ketones. Second, they used continuous monitoring to distinguish between a healthy, controlled metabolic state and a dangerous one. While high levels of ketones can sometimes indicate a life-threatening condition called ketoacidosis, in this patient, the levels were part of a stable, managed state that kept her brain functioning. The doctors also prepared a contingency plan in case her condition changed, ready to adjust fluids or provide alternative energy sources if necessary, though these measures were not needed.

This report highlights that the standard rules of perioperative care must be adapted for patients with unique metabolic needs. For a person with Glucose Transporter Type 1 Deficiency Syndrome, the brain's reliance on fat-derived fuel is absolute. The team's approach suggests that by prioritizing the preservation of this metabolic state and avoiding unnecessary glucose, surgeons can safely operate on these patients. While this was a single case involving a relatively short surgery, it provides a practical blueprint for future care. It shows that with the right monitoring and a willingness to deviate from routine protocols, the brain can remain well-fueled even when the body is under the stress of surgery.